DESIGN AND EVALUATION OF NEOMYCIN SULFATE-LOADED SOLID LIPID NANOPARTICLES (SLNs) FOR OCULAR ADMINISTRATION
DOI:
https://doi.org/10.22159/ijap.2025v17i5.54617Keywords:
SLNs, Neomycin sulfate, DoE, Particle size, Zeta potential, HET-CAM testAbstract
Objective: The current study aimed to formulate and evaluate solid lipid nanoparticles (SLNs) loaded with Neomycin Sulfate for ocular administration for the management of bacterial conjunctivitis.
Methods: The formulation of Neomycin Sulfate-loaded SLNs was carried out using the solvent evaporation and ultrasonication methods. Optimization of SLNs was performed using a 32 full factorial statistical design, and the optimized batch of SLNs was evaluated for various parameters.
Results: The optimized formulation exhibited a mean particle size of 178.2±2.23 nm with an entrapment efficiency of 85.6%, which was in good agreement with the predicted values obtained using Design Expert software. The formulation revealed a sustained drug release pattern with a maximum drug release of 82.11±0.34% lasting 8 h with Higuchi's drug release kinetics mechanism. The Hen’s egg test-Chorioallantoic membrane (HET-CAM) assay revealed that the optimized formulation was non-irritating and non-toxic for ocular use. Additionally, histopathological analysis showed no structural damage to the cornea, confirming the formulation’s safety for ocular administration. Short-term stability studies on the optimized formulation demonstrated that it remained stable, with no notable changes in the assessed parameters over 3 mo.
Conclusion: From the above outcomes of the study results, we conclude that Neomycin sulfate-loaded SLNs could be a potential drug delivery approach for the treatment of bacterial conjunctivitis in the eye.
References
1. Seyfoddin A, Shaw J, Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv. 2010;17(7):467-89. doi: 10.3109/10717544.2010.483257, PMID 20491540.
2. Snyder RW, Glasser DB. Antibiotic therapy for ocular infection. West J Med. 1994;161(6):579-84. PMID 7856158.
3. Khames A, Khaleel MA, El-Badawy MF, El-Nezhawy AO. Natamycin solid lipid nanoparticles-sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. IJN. 2019;14:2515-31. doi: 10.2147/IJN.S190502.
4. Duong VA, Nguyen TT, Maeng HJ. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules. 2020;25(20):4781. doi: 10.3390/molecules25204781, PMID 33081021.
5. Ghasemiyeh P, Mohammadi Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13(4):288-303. doi: 10.4103/1735-5362.235156, PMID 30065762.
6. Hosny KM, Naveen NR, Kurakula M, Sindi AM, Sabei FY, Fatease AA. Design and development of neomycin sulfate gel loaded with solid lipid nanoparticles for buccal mucosal wound healing. Gels. 2022;8(6):385. doi: 10.3390/gels8060385, PMID 35735729.
7. Mulani H, Bhise KS. QbD approach in the formulation and evaluation of miconazole nitrate-loaded ethosomal cream-o-gel. Int Res J Pharm Sci. 2017;8(1):1-37.
8. Hosny KM, Naveen NR, Kurakula M, Sindi AM, Sabei FY, Fatease AA. Design and development of neomycin sulfate gel loaded with solid lipid nanoparticles for buccal mucosal wound healing. Gels. 2022;8(6):385. doi: 10.3390/gels8060385, PMID 35735729.
9. Patil J, Rajput R, Nemade R, Naik J. Preparation and characterization of artemether-loaded solid lipid nanoparticles: a 32 factorial design approach. Materials Technology. 2020;35(11-12):719-26. doi: 10.1080/10667857.2018.1475142.
10. Weissman SA, Anderson NG. Design of experiments (DoE) and process optimization. A review of recent publications. Org Process Res Dev. 2015;19(11):1605-33. doi: 10.1021/op500169m.
11. Kraisit P, Hirun N, Mahadlek J, Limmatvapirat S. Fluconazole-loaded solid lipid nanoparticles (SLNs) as a potential carrier for buccal drug delivery of oral candidiasis treatment using the Box-Behnken design. J Drug Deliv Sci Technol. 2021;63:1024-37. doi: 10.1016/j.jddst.2021.102437.
12. Kelidari HR, Saeedi M, Akbari J, Morteza Semnani K, Gill P, Valizadeh H. Formulation optimization and in vitro skin penetration of spironolactone-loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2015;128:473-9. doi: 10.1016/j.colsurfb.2015.02.046, PMID 25797482.
13. Öztürk AA, Yenilmez E, Şenel B, Kıyan HT, Güven UM. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and in vivo anti-inflammatory effect by using HET-CAM assay. Drug Dev Ind Pharm. 2020;46(4):682-95. doi: 10.1080/03639045.2020.1755304, PMID 32281428.
14. Mahmoud RA, Hussein AK, Nasef GA, Mansour HF. Oxiconazole nitrate solid lipid nanoparticles: formulation, in vitro characterization and clinical assessment of an analogous loaded carbopol gel. Drug Dev Ind Pharm. 2020;46(5):706-16. doi: 10.1080/03639045.2020.1752707, PMID 32266837.
15. de Campos AM, Diebold Y, Carvalho EL, Sánchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res. 2004;21(5):803-10. doi: 10.1023/b:pham.0000026432.75781.cb, PMID 15180338.
16. Shirisha S, Saraswathi A, Sahoo SK, Rao YM. Formulation and evaluation of nisoldipine-loaded solid lipid nanoparticles and nanostructured lipid carriers: application to transdermal delivery. Ind J Pharm Educ Res. 2020;54(2s):s117-27. doi: 10.5530/ijper.54.2s.68.
17. Iriventi P, Gupta NV, Osmani RA, Balamuralidhara V. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. Daru. 2020;28(2):489-506. doi: 10.1007/s40199-020-00352-x, PMID 32472531.
18. Patel AH, Dave RM. Formulation and Evaluation of Sustained Release in situ ophthalmic Gel of neomycin sulphate. Bol Pharm Res. 2015;5(1):1-5.
19. Gokhale JP, Mahajan HS, Surana SJ. Quercetin-loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies. Biomed Pharmacother. 2019;112:108622. doi: 10.1016/j.biopha.2019.108622, PMID 30797146.
20. Supriya A, Sundaraseelan J, Srinivas Murthy BR, Bindu Priya M. Formulation and in vitro characterization of neomycin-loaded chitosan nanoparticles. Acta Sci Pharm Sci. 2018;2(2):34-40.
21. Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217-23. PMID 20524422.
22. Lokhandwala H, Deshpande A, Deshpande SH. Kinetic modeling and dissolution profiles comparison: an overview. Int J Pharm Bio Sci. 2013;4(1):728-33.
23. Sah AK, Suresh PK, Verma VK. PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study. Artif Cells Nanomed Biotechnol. 2017;45(6):1-9. doi: 10.1080/21691401.2016.1203794, PMID 27389068.
24. Indian pharmacopoeia. 6th ed. Vol. 1. New Delhi: Controller of Publications. Ministry of Health and Family Welfare; 2007. p. 56-60.
25. Ganesh NS, Ashir TP, Vineeth C. Review on approaches and evaluation of in situ ocular drug delivery system. Int Res J Pharm Biosci. 2017;4(3):23-33.
26. Wilson SL, Ahearne M, Hopkinson A. An overview of current techniques for ocular toxicity testing. Toxicology. 2015;327:32-46. doi: 10.1016/j.tox.2014.11.003, PMID 25445805.
27. Khan N, Aqil M, Imam SS, Ali A. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization. Pharm Dev Technol. 2015;20(6):662-9. doi: 10.3109/10837450.2014.910807, PMID 24754411.
28. Sun K, Hu K. Preparation and characterization of tacrolimus-loaded SLNs in situ gel for ocular drug delivery for the treatment of immune conjunctivitis. Drug Des Dev Ther. 2021;15:141-50. doi: 10.2147/DDDT.S287721, PMID 33469266.
29. Bachu RD, Chowdhury P, Al-Saedi ZH, Karla PK, Boddu SH. Ocular drug delivery barriers-Role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10(1):28. doi: 10.3390/pharmaceutics10010028, PMID 29495528.
Published
How to Cite
Issue
Section
Copyright (c) 2025 VEEKSHA S. SHETTY, SANDEEP DS
This work is licensed under a Creative Commons Attribution 4.0 International License.
